Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia

J Cortes, SM O'Brien, S Pierce, MJ Keating, EJ Freireich, HM Kantarjian

Blood (1995) 86 (6): 2091–2097.

https://doi.org/10.1182/blood.V86.6.2091.bloodjournal8662091

Published: 1995

Journal Articles

2-chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia

JF Seymour, R Kurzrock, EJ Freireich, EH Estey

Blood (1994) 83 (10): 2906–2911.

https://doi.org/10.1182/blood.V83.10.2906.2906

Published: 1994

Journal Articles

When to give platelet transfusions [letter; comment]

EJ Freireich

Blood (1993) 82 (2): 682–683.

https://doi.org/10.1182/blood.V82.2.682.682

Published: 1993

Journal Articles

Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent

MJ Keating, S O'Brien, H Kantarjian, W Plunkett, E Estey, C Koller, M Beran, EJ Freireich

Blood (1993) 81 (11): 2878–2884.

https://doi.org/10.1182/blood.V81.11.2878.2878

Published: 1993

Journal Articles

Detection of minimal residual disease by polymerase chain reaction in Philadelphia chromosome-positive chronic myelogenous leukemia following interferon therapy

MS Lee, H Kantarjian, M Talpaz, EJ Freireich, A Deisseroth, JM Trujillo, SA Stass

Blood (1992) 79 (8): 1920–1923.

https://doi.org/10.1182/blood.V79.8.1920.1920

Published: 1992

Journal Articles

Specific expression of the annexin VIII gene in acute promyelocytic leukemia

KS Chang, G Wang, EJ Freireich, M Daly, SL Naylor, JM Trujillo, SA Stass

Blood (1992) 79 (7): 1802–1810.

https://doi.org/10.1182/blood.V79.7.1802.1802

Published: 1992

Journal Articles

The t(15;17) breakpoint in acute promyelocytic leukemia cluster within two different sites of the myl gene: targets for the detection of minimal residual disease by the polymerase chain reaction

KS Chang, JF Lu, G Wang, JM Trujillo, E Estey, A Cork, DT Chu, EJ Freireich, SA Stass

Blood (1992) 79 (3): 554–558.

https://doi.org/10.1182/blood.V79.3.554.554

Published: 1992

Journal Articles

RAS mutations are rare events in Philadelphia chromosome-negative/bcr gene rearrangement-negative chronic myelogenous leukemia, but are prevalent in chronic myelomonocytic leukemia

C Hirsch-Ginsberg, AC LeMaistre, H Kantarjian, M Talpaz, A Cork, EJ Freireich, JM Trujillo, MS Lee, SA Stass

Blood (1990) 76 (6): 1214–1219.

https://doi.org/10.1182/blood.V76.6.1214.1214

Published: 1990

Journal Articles

Mixed-lineage leukemia revisited: acute lymphocytic leukemia with myeloperoxidase-positive blasts by electron microscopy [see comments]

HM Kantarjian, C Hirsch-Ginsberg, G Yee, Y Huh, EJ Freireich, S Stass

Blood (1990) 76 (4): 808–813.

https://doi.org/10.1182/blood.V76.4.808.808

Published: 1990

Journal Articles

Treatment of poor-prognosis, newly diagnosed acute myeloid leukemia with ara-C and recombinant human granulocyte-macrophage colony- stimulating factor

EH Estey, D Dixon, HM Kantarjian, MJ Keating, K McCredie, GP Bodey, R Kurzrock, M Talpaz, EJ Freireich, AB Deisseroth

Blood (1990) 75 (9): 1766–1769.

https://doi.org/10.1182/blood.V75.9.1766.1766

Published: 1990

Journal Articles

Peripheral acute leukemia: high peripheral but low-marrow blast count

JD Cason, JM Trujillo, EH Estey, YO Huh, EJ Freireich, SA Stass

Blood (1989) 74 (5): 1758–1761.

https://doi.org/10.1182/blood.V74.5.1758.1758

Published: 1989

Journal Articles

Fludarabine: a new agent with major activity against chronic lymphocytic leukemia

MJ Keating, H Kantarjian, M Talpaz, J Redman, C Koller, B Barlogie, W Velasquez, W Plunkett, EJ Freireich, KB McCredie

Blood (1989) 74 (1): 19–25.

https://doi.org/10.1182/blood.V74.1.19.19

Published: 1989

Journal Articles

Detection of two alternative bcr/abl mRNA junctions and minimal residual disease in Philadelphia chromosome positive chronic myelogenous leukemia by polymerase chain reaction

MS Lee, A LeMaistre, HM Kantarjian, M Talpaz, EJ Freireich, JM Trujillo, SA Stass

Blood (1989) 73 (8): 2165–2170.

https://doi.org/10.1182/blood.V73.8.2165.2165

Published: 1989

Journal Articles

Ras oncogene mutations are rare late stage events in chronic myelogenous leukemia

A LeMaistre, MS Lee, M Talpaz, HM Kantarjian, EJ Freireich, AB Deisseroth, JM Trujillo, SA Stass

Blood (1989) 73 (4): 889–891.

https://doi.org/10.1182/blood.V73.4.889.889

Published: 1989

Journal Articles

Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia

HM Kantarjian, RS Walters, TL Smith, MJ Keating, B Barlogie, KB McCredie, EJ Freireich

Blood (1988) 72 (5): 1784–1789.

https://doi.org/10.1182/blood.V72.5.1784.1784

Published: 1988

Journal Articles

Detection of minimal residual bcr/abl transcripts by a modified polymerase chain reaction

MS Lee, KS Chang, EJ Freireich, HM Kantarjian, M Talpaz, JM Trujillo, SA Stass

Blood (1988) 72 (3): 893–897.

https://doi.org/10.1182/blood.V72.3.893.893

Published: 1988

Journal Articles

HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3

WT Jr Dalton, MJ Ahearn, KB McCredie, EJ Freireich, SA Stass, JM Trujillo

Blood (1988) 71 (1): 242–247.

https://doi.org/10.1182/blood.V71.1.242.242

Published: 1988

Journal Articles

Phenotypic and molecular heterogeneity in Philadelphia chromosome- positive acute leukemia

C Hirsch-Ginsberg, C Childs, KS Chang, M Beran, A Cork, J Reuben, EJ Freireich, LC Chang, FJ Bollum, J Trujillo

Blood (1988) 71 (1): 186–195.

https://doi.org/10.1182/blood.V71.1.186.186

Published: 1988

Journal Articles

Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival

HM Kantarjian, TL Smith, KB McCredie, MJ Keating, RS Walters, M Talpaz, JP Hester, G Bligham, E Gehan, EJ Freireich

Blood (1985) 66 (6): 1326–1335.

https://doi.org/10.1182/blood.V66.6.1326.1326

Published: 1985

Journal Articles

Preferential expression of double-stranded ribonucleic acid in tumor versus normal cells: biological and clinical implications

HM Kantarjian, B Barlogie, M Pershouse, D Swartzendruber, MJ Keating, KB McCredie, EJ Freireich

Blood (1985) 66 (1): 39–46.

https://doi.org/10.1182/blood.V66.1.39.39

Published: 1985

NARROW

The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia

2-chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia

When to give platelet transfusions [letter; comment]

Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent

Detection of minimal residual disease by polymerase chain reaction in Philadelphia chromosome-positive chronic myelogenous leukemia following interferon therapy

Specific expression of the annexin VIII gene in acute promyelocytic leukemia

The t(15;17) breakpoint in acute promyelocytic leukemia cluster within two different sites of the myl gene: targets for the detection of minimal residual disease by the polymerase chain reaction

RAS mutations are rare events in Philadelphia chromosome-negative/bcr gene rearrangement-negative chronic myelogenous leukemia, but are prevalent in chronic myelomonocytic leukemia

Mixed-lineage leukemia revisited: acute lymphocytic leukemia with myeloperoxidase-positive blasts by electron microscopy [see comments]

Treatment of poor-prognosis, newly diagnosed acute myeloid leukemia with ara-C and recombinant human granulocyte-macrophage colony- stimulating factor

Peripheral acute leukemia: high peripheral but low-marrow blast count

Fludarabine: a new agent with major activity against chronic lymphocytic leukemia

Detection of two alternative bcr/abl mRNA junctions and minimal residual disease in Philadelphia chromosome positive chronic myelogenous leukemia by polymerase chain reaction

Ras oncogene mutations are rare late stage events in chronic myelogenous leukemia

Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia

Detection of minimal residual bcr/abl transcripts by a modified polymerase chain reaction

HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3

Phenotypic and molecular heterogeneity in Philadelphia chromosome- positive acute leukemia

Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival

Preferential expression of double-stranded ribonucleic acid in tumor versus normal cells: biological and clinical implications

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only